Holen Sie sich die Stockscreener-App
4.95
1.79%
-0.09
Handel nachbörslich:
4.90
-0.05
-1.01%
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
Ardelyx Inc (ARDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ARDX|Ardelyx Inc|Price:5.030|Chg%:-0.100 - TradingKey
Ardelyx Inc (ARDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ardelyx Inc (ARDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ardelyx (ARDX) Faces A Valuation Test, Is The Discount Too Wide? - simplywall.st
TradingKey - TradingKey
Ardelyx Inc (ARDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
Ardelyx Inc (ARDX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Ardelyx, Inc. Revenue Breakdown – NASDAQ:ARDX - TradingView
Ardelyx, Inc. (ARDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Ardelyx Inc (ARDX) Institutional Confidence - TradingKey
Ardelyx, Inc. (ARDX) stock price, news, quote and history - Yahoo Finance Singapore
Ardelyx Schedules Second Quarter 2026 Financial Results Webcast for August 6, 2026 - scanx.trade
ARDX: Ardelyx Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026 - The Manila Times
Ardelyx schedules webcast, call to discuss Q2 results and business update - Bitget
ARDX Q1 2026 Earnings: EPS Misses Estimates as Revenue Details Remain UnavailableBanking Earnings Report - po-news-eg.net
ETFs Investing in Ardelyx, Inc. Stocks - TradingView
How Investors Are Reacting To Ardelyx (ARDX) Hedge Fund Buying Despite Medicare Setback - simplywall.st
Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts - Yahoo Finance
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? - Stocktwits
High Growth Tech Stocks In The US Market - simplywall.st
Ardelyx (ARDX) Pulls Back As Growth Narrative Raises The Question Of Value - simplywall.st
Ardelyx CEO Michael Raab disposes of 41,668 common shares worth $210,884.22 - Bitget
Form 4 Ardelyx Inc For: 17 July By Investing.com - Investing.com Nigeria
Ardelyx CEO Michael Raab sells $210,923 in stock By Investing.com - Investing.com South Africa
Ardelyx CEO Michael Raab sells $210,923 in stock - Investing.com
Form 4 Ardelyx Inc For: 17 July - Investing.com India
Ardelyx CEO sells shares, exercises options | ARDX Insider Trading - Stock Titan
Lobbying Update: $500,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
Trading the Move, Not the Narrative: (ARDX) Edition - Stock Traders Daily
Ardelyx (ARDX) Receives a Buy from Wedbush - The Globe and Mail
Wedbush Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $19 - Moomoo
Lobbying Update: $20,000 of ARDELYX INC lobbying was just disclosed - Quiver Quantitative
Ardelyx Secures New $50 Million Term F Loan - The Globe and Mail
Ardelyx (NASDAQ: ARDX) draws $50M Term F loan maturing in 2030 - Stock Titan
Ardelyx: The Market Is Right To Discount This Revenue Growth - Seeking Alpha
Price to book forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Enterprise value to revenue forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Enterprise value to EBITDA forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Price to sales forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Price to earnings forward of Ardelyx, Inc. – TRADEGATE:41X - TradingView
Ardelyx, Inc.'s (NASDAQ:ARDX) Shift From Loss To Profit - 富途牛牛
Ardelyx (ARDX) Faces New Medicare Rules For Xphozah After Court Ruling - simplywall.st
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):